INO
Inovio Pharmaceuticals Inc
Price:  
11.06 
USD
Volume:  
306,406.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO EV/EBITDA

-869.6%
Upside

As of 2024-07-16, the EV/EBITDA ratio of Inovio Pharmaceuticals Inc (INO) is -2.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INO's latest enterprise value is 266.96 mil USD. INO's TTM EBITDA according to its financial statements is -119.46 mil USD. Dividing these 2 quantities gives us the above INO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.2x - 21.4x 16.0x
Forward P/E multiples 17.5x - 24.0x 21.2x
Fair Price (79.84) - (97.73) (85.12)
Upside -821.9% - -983.6% -869.6%
11.06 USD
Stock Price
(85.12) USD
Fair Price

INO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-15 -2.23
2024-07-12 -2.29
2024-07-11 -2.23
2024-07-10 -1.85
2024-07-09 -1.82
2024-07-08 -1.72
2024-07-05 -1.77
2024-07-03 -1.64
2024-07-02 -1.66
2024-07-01 -1.70
2024-06-28 -1.59
2024-06-27 -1.52
2024-06-26 -1.53
2024-06-25 -1.50
2024-06-24 -1.56
2024-06-21 -1.59
2024-06-20 -1.59
2024-06-18 -1.69
2024-06-17 -1.77
2024-06-14 -1.81
2024-06-13 -1.89
2024-06-12 -1.89
2024-06-11 -1.94
2024-06-10 -1.94
2024-06-07 -1.92
2024-06-06 -2.01
2024-06-05 -2.03
2024-06-04 -2.02
2024-06-03 -2.04
2024-05-31 -2.03
2024-05-30 -1.95
2024-05-29 -2.01
2024-05-28 -2.09
2024-05-24 -2.22
2024-05-23 -2.21
2024-05-22 -2.28
2024-05-21 -2.22
2024-05-20 -2.25
2024-05-17 -2.44
2024-05-16 -2.61
2024-05-15 -2.67
2024-05-14 -2.31
2024-05-13 -2.30
2024-05-10 -2.15
2024-05-09 -2.26
2024-05-08 -2.22
2024-05-07 -2.25
2024-05-06 -2.41
2024-05-03 -2.46
2024-05-02 -2.44